Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, AtLaS pilot study)

Simona Di Giambenedetto, Massimiliano Fabbiani, Manuela Colafigli, Nicoletta Ciccarelli, Salvatore Farina, Letizia Sidella, Alessandro D'Avino, Annalisa Mondi, Antonella Cingolani, Enrica Tamburrini, Rita Murri, Pierluigi Navarra, Roberto Cauda, Andrea De Luca

Risultato della ricerca: Contributo in rivista › Articolo in rivista

45 Citazioni (Scopus)

Fingerprint

Entra nei temi di ricerca di 'Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, AtLaS pilot study)'. Insieme formano una fingerprint unica.

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science